C
Merck & Co., Inc. MRK
$113.82 $1.451.29% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2026 12/31/2025 09/30/2025 06/30/2025 03/31/2025
Net Income -48.75% 6.64% 56.68% 19.44% 656.03%
Total Depreciation and Amortization 13.69% 9.26% 7.44% 13.35% 19.10%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 189.43% -85.26% -94.43% 157.54% -73.34%
Change in Net Operating Assets -22.02% -90.24% -290.41% -152.97% -48.20%
Cash from Operations -14.31% -23.27% -6.56% 11.05% 41.48%
Capital Expenditure 1.67% -21.95% -17.29% -7.59% -3.28%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -462.32% -145.35% 99.95% -348.66% 70.77%
Divestitures -- -- -- -- --
Other Investing Activities 120.03% 253.53% -97.34% -124.76% -131.87%
Cash from Investing -186.35% -77.67% 36.12% -176.82% 40.11%
Total Debt Issued 315.14% 285.66% 67.41% -97.16% -39.40%
Total Debt Repaid 62.39% -94.03% -303.18% -302.52% -21.32%
Issuance of Common Stock 111.01% -48.02% -66.67% -72.25% -40.11%
Repurchase of Common Stock -104.17% -289.28% -257.11% -179.38% -78.01%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -3.66% -4.29% -4.75% -5.08% -5.28%
Other Financing Activities 57.34% 64.78% 11.71% -5.47% -8.92%
Cash from Financing 108.54% 72.67% -54.47% -81.77% -79.05%
Foreign Exchange rate Adjustments 38,700.00% 292.15% -33.46% 339.27% 100.50%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -208.92% -78.59% -40.65% -158.29% 174.39%